Article

Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)

2021-03-26

Abstract excerpt

<h4>Summary</h4> Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is an only state-of-art treatment option for the CUP patient. Employing molecular profiling of the tumour, particularly mutation detection, offers a new treatment for CUP in a personalized fashion. Here, we analyzed mutation and copy number alterat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5bb487d7-c05c-559b-99eb-5e481a9c933e
DOI: 10.1101/2021.03.25.436921

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)DOI 10.1101/2021.03.25.436921Read

Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)Semantic proximity Read

Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP).Semantic proximity Read

Genetic characterisation of molecular targets in carcinoma of unknown primary.Semantic proximity Read

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.Semantic proximity Read

Molecular driver alterations and their clinical relevance in cancer of unknown primary site.Semantic proximity Read

Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.Semantic proximity Read

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Semantic proximity Read

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.Semantic proximity Read

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.Semantic proximity Read

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity Read

Comprehensive ctDNA Profiling Enables Tissue-of-Origin Prediction and Actionable Biomarker Detection in Cancer of Unknown PrimarySemantic proximity Read